Indication, march 2011

In this issue of Indication you can read about:

The Danish Medicines Agency's new strategy 'Perspectives and challenges 2011-2016.
How companies and scientists can save resources by applying for approval of a clinical trial through the European Voluntary Harmonisation Procedure.
The daily work of evaluating serious side effects.
The differences between men and women - and whether these differences should be reflected in the development of new medicine.

Created 15 April 2011

Themes Publications Questions and answers Sitemap

Access-controlled extranet, which offers companies easy and secure access to sending and receiving information.

Danish Health and Medicines Authority
Axel Heides Gade 1
2300 Copenhagen S, Denmark